By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agricultural genomics company Floragenex has received a strategic investment from Illinois Foundation Seeds, a research and licensing company focused on corn technologies.

Floragenex did not disclose the amount of the investment, which gives Illinois Foundation Seeds access to technology for research and breeding efforts in the dent corn and sweet corn markets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.